J9国际站 J9

【Good News】Shenzhen Cell Valley Re-elected as Member of Shenzhen Biomedicine Industry-Education Alliance “Outstanding Council Unit” & Professor Shi Yuan-Yuan Again Honored as “Outstanding Industry Me

Date:10-30  Hits:  Belong to:News & Events


Recently, the 2025 Annual Conference of the Shenzhen Biomedicine Industry-Education Alliance was grandly held at Shenzhen Polytechnic University (hereinafter referred to as “Shenzhen PolyU”). As the Vice Chair Unit of the Shenzhen Biomedicine Industry-Education Alliance, Shenzhen Cell Valley was invited to attend the conference. Under the theme “Integration Drives Development, Collaboration Shapes the Future,” the event brought together representatives from government, universities, enterprises, and research institutions to discuss pathways for deeper industry-education integration.

图片.png

图片.png

图片.png

图片.png

After uation by the alliance, Shenzhen Cell Valley was once again honored as the “Outstanding Council Unit” (consecutively for 2024–2025). Additionally, our Chairman Professor Shi Yuan-Yuan was recognized as an “Outstanding Industry Mentor”. These dual honors not only affirm the company’s annual achievements in viral vector industrialization, cell therapy drug translation, and talent cultivation but also highlight Shenzhen Cell Valley’s exemplary leadership role within the alliance ecosystem.

Since becoming the Vice Chair Unit of the Shenzhen Biomedicine Industry-Education Alliance in 2023, Shenzhen Cell Valley has consistently built a “Research-Translation-Talent” closed loop: collaborating with universities like Shenzhen PolyU to compile textbooks, offer undergraduate courses in theory and practice, and issue vocational skill certification, training 30+ biomedicine professionals annually to alleviate industry talent shortages at the source. Chairman Professor Shi Yuan-Yuan stated that the company will leverage this honor as motivation to further deepen industry-education collaboration, establish a talent hub for the cell therapy industry, and contribute to the advancement of the field.

Group Photo

图片.png


About Us
Scan to follow our latest newsScan to follow our latest news
Contact Us
400-800-1266

Working hours: Monday to Friday, 9:00-18:00

Contact:Ms. Lai

Email:laijiaqi@lwfzch.com

Address:No. 1, Rongtian Road, Jinsha Community, Kengzi Street, Pingshan District, Shenzhen, China (Hepure Biomedical Ecological Park)

Shenzhen Cell Valley Biopharmaceutical Co., Ltd. is a leading one-stop comprehensive outsourcing service provider for China’s cell and gene therapy industry. It is also among the first domestic CRO/CDMO enterprises to hold GMP-compliant industrial production capabilities for clinical-grade retroviral vectors. As a key project for the construction of Shenzhen’s public technical service platform for CRO/CDMO, the company has been listed in the city’s newly announced "20+8" strategic emerging industries initiative.
Shenzhen Cell Valley is equipped with the capacity to conduct standardized and industrialized production of GMP-grade cellular products including CAR-T cells. Its core production lines cover a full spectrum of cellular products such as CAR-T, CAR-NK, CAR-M, γδT, TIL and TCR-T. In addition, the company runs production lines for a diverse range of viral vectors (including RVV, LVV and AAV) and non-viral vectors, as well as for cellular raw materials for therapeutic development—such as exosomes, genetically engineered antibodies, cytokines, oncolytic viruses and vaccines.
 Copyright 粤ICP备2024168379号 互联网药品信息服务资格证书:(粤)-非经营性-2022-0426  Technical Support:YouDian Software